Physician profile
Tammy Davis
NPI 1184081234
$3,038.96
in general payments reported to CMS, 2019-2025
24 companies · $552 in 2025
The $552 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $528 · 2022: $1,002 · 2023: $198 · 2024: $760 · 2025: $552.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,469 · Education: $40.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,468.80 |
| Education | $40.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hydrofera LLC | $851.50 | 2022-2025 | Hydrofera Blue, Cutimed Sorbion, Sorbact Other |
| Smith+Nephew, INC. | $359.98 | 2021-2024 | Collagenase Santyl |
| Organogenesis INC. | $312.24 | 2021-2022 | |
| Davol INC. | $273.08 | 2023-2025 | Phasix Mesh, Channel Drain, Arista Ah Flexitip |
| Intuitive Surgical, INC. | $237.66 | 2021-2023 | Da Vinci Surgical System |
| Abbvie INC. | $199.07 | 2021-2025 | |
| Abbott Laboratories | $148.44 | 2022 | |
| Solventum Corporation | $140.07 | 2024-2025 | V.A.C. Veraflo Cleanse Choice, Promogran Prisma, Activ.A.C. Ion Progress |
| Medtronic, INC. | $89.29 | 2024-2025 | Interstim, Signia |
| Kerecis Limited | $66.14 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Convatec INC. | $64.44 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $37.90 | 2022 | |
| Kci USA, INC. | $35.09 | 2023 | V.A.C. Veraflo Cleanse Choice |
| Reprise Biomedical, INC. | $33.98 | 2025 | Miro3d, Miro 3d |
| Allergan, INC. | $31.20 | 2021-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $24.54 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $23.00 | 2023 | Exparel |
| Conmed Corporation | $22.03 | 2025 | Airseal |
| Triad Life Sciences INC. | $19.76 | 2022 | |
| Paratek Pharmaceuticals, INC. | $16.59 | 2023 | Nuzyra |
| Boston Scientific Corporation | $14.72 | 2022 | |
| Misonix INC | $13.87 | 2021 | |
| Heron Therapeutics, INC. | $12.76 | 2022 | |
| Hollister Incorporated | $11.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tammy Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.